The biochemical investigation of epilepsy in childhood

Seizure

Volumn 6, Issue 3, 1997, Pages 193-200

  Gibbs, J ^a   Appleton, R E ^b  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adolescence; Biochemical; Childhood; Epilepsy; Metabolic; Seizures

Indexed keywords

ARTICLE; BIOCHEMISTRY; CHILD; CLINICAL EXAMINATION; ELECTROENCEPHALOGRAM; EPILEPSY; FAMILY HISTORY; HUMAN; IMAGING; METABOLIC DISORDER; ONSET AGE; PRIORITY JOURNAL; SCREENING TEST; SEIZURE;

EID: 0030814127     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(97)80005-2     Document Type: Article

References (46)

1. Cohen, B.H. Metabolic and degenerative diseases associated with epilepsy. Epilepsia 1993; 34: 562-570.
2. Nypaver, M.M., Reynolds, S.L., Tanz, R.R. and Davis, A.T. Emergency department laboratory evaluation of children with seizures: dogma or dilemma? Pediatric Emergency Care 1992; 8: 13-16.
3. Kenney, R.D. and Taylor, J.A. Absence of serum chemistry abnormalities in pediatric patients presenting with seizures. Pediatric Emergency Care 1992; 8: 65-66.
4. Appleton, R.E. Treatment of childhood epilepsy. Pharmacology and Therapeutics 1995; 67: 419-431.
5. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985; 26: 268-278.
6. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-399.
7. Aicardi, J. Epilepsy and inborn errors of metabolism. In: (Eds J. Roger, M. Bureau, Ch. Dravet, F.E. Dreifuss, A. Perret and P. Wolf) Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd Edition. 1992; London: John Libbey pp. 97-102.
8. Berkovic, S.F., Andermann, F., Carpenter, S. and Wolfe, L.S. Progressive myoclonus epilepsies: specific causes and diagnosis. New England Journal of Medicine 1986; 315: 296-305.
9. Dulac, O., Chugani, H.T. and Dalla Bernardina, B. (Eds). Infantile Spasms and West Syndrome. Philadelphia: W.B. Saunders, 1994.
10. Cockburn, F., Brown, J.K., Belton, N.R. and Forfar, J.O. Neonatal convulsions associated with primary disturbance of calcium, phosphorus, and magnesium metabolism. Archives of Disease in Childhood 1973; 48: 99-108.
11. Lahat, E., Barr, J. and Bistritzer, T. Focal epileptic episodes associated with hypoglycaemia in children with diabetes. Clinical Neurology and Neurosurgery 1995; 97: 314-316.
12. Columaria, V., Burlina, A.B., Gaburro, D. et al. Biotin-responsive infantile encephalopathy: EEG-polygraphic study of a case. Epilepsia 1989; 30: 573-578.
13. Dalla Bernardina, B., Aidardi, J., Goutières, F. and Plouin, P. Glycine encephalopathy. Neuropediatrie 1979; 10: 209-225.
14. Saudubray, J.M., Ogier, H., Bonnefont, J.P. et al. Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. Journal of Inherited Metabolic Disease 1989; 30: 25-41.
15. Borden, M. Screening for metabolic disease. In: (W.L. Nyhan). Abnormalities in Amino Acid Metabolism in Clinical Medicine. Connecticut: Appleton-Century-Crofts, 1984, pp. 401-418.
16. Adams, R.D. and Lyon, G. Neurology of Hereditary Metabolic Diseases of Children. New York: McGraw-Hill. 1982.
17. Calciolari, G., Perlman, J.M. and Volpe, J.J. Seizures in the neonatal intensive care unit of the 1980s. Types, etiologies, timing. Clinical Pediatrics 1988; 27: 119-123.
18. Tharp, B.R. Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease. Pediatric Neurology 1992; 8: 65-68.
19. Mikati, M.A., Trevathan, E., Krishnamoorthy, K.S. and Lombroso, C.T. Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalography and Clinical Neurophysiology 1991; 78: 215-221.
20. Pampiglione, G. and Harden, A. So-called neuronal ceroid lipofuscinosis. Neurophysiological studies in 60 children. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 323-330.
21. Tulinius, M.H. and Hagne, I. EEG findings in children and adolescents with mitochondrial encephalomyopathies: a study of 25 cases. Brain Development 1991; 13: 167-173.
22. Morris, A.A.M., Singh-Kler, R., Perry, R.H. et al. Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. Journal of Child Neurology 1996; 11: 417-419.
23. Boyd, S.G., Harden, A., Egger, J. and Pampiglione, G. Progressive neuronal degeneration of childhood with liver disease ('Alper's disease'): characteristic neurophysiological features. Neuropediatrics 1986; 17: 75-80.
24. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. The Metabolic Basis of Inherited Disease. 7th Edition. New York: McGraw-Hill, 1995, (Volumes I, II and III).
25. Volpe, J.J. Metabolic encephalopathies. In: (J.J. Volpe). Neurology of the Newborn. 3rd Edition. Philadelphia: W.B. Saunders, 1995. pp. 465-582.
26. Rezvani, I., Auerbach, V.H., Matalon, R.H. et al. Metabolic diseases. In: (Ed R.E. Behrman), Nelson Textbook of Pediatrics. 14th Edition. Philadelphia: W.B. Saunders, 1992, pp. 305-419.
27. Buist, N.R.M. (Ed). Inborn errors of metabolism. In: (Eds A.G.M. Campbell & N. McIntosh). Forfar and Arneil's Textbook of Paediatrics. 4th Edition. Edinburgh: Churchill Livingstone, 1992. pp. 1173-1255.
28. Ogier, H. and Aicardi, J. Metabolic and heredodegenerative disorders of the CNS. In: (J. Aicardi). Diseases of the Nervous System in Childhood. London: Mackeith Press. 1992. pp. 375-588.
29. Menkes, J.H. Metabolic diseases of the nervous system. In: (J.H. Menkes). Textbook of Child Neurology 5th Edition. Baltimore: Williams and Wilkins, 1995, pp. 29-151.
30. Jackson, M.J., Shaefer, J.A., Johnson, M.A., Morris, A.A., Turnbull, D.M. and Bindoff, L.A. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 1995; 118: 339-357.
31. Robinson, B.H., MacMillan, H., Petrova-Benedict, R. and Sherwood, G. Variable clinical presentation in patients with defective El component of pyruvate dehydrogenase complex. Journal of Pediatrics 1987; 111: 525-533.
32. Danks, D.M., Tippett, P., Adams, C. and Campbell, P. Cerebrohepatorenal syndrome of Zellweger. Journal of Pediatrics 1975; 86: 382-387.
33. Endres, W., Shin, Y.S., Günther, R., Ibel, H., Duran, M. and Wadman, S.K. Report on a new patient with combined deficiencies of sulphite oxidase and xanthine dehydrogenase due to molybdenum cofactor deficiency. European Journal of Pediatrics 1988; 1348: 246-249.
34. Bamforth, F., Bamforth, S., Poskitt, K., Applegarth, D. and Hall, J. Abnormalities of corpus callosum in patients with inherited metabolic diseases. Lancet 1988; 2: 451.
35. Baxter, P., Griffiths, P., Kelly, T. and Gardner-Medwin, D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Developmental Medicine and Child Neurology 1996; 38: 998-1006.
36. Collins, J. A practical approach to to the diagnosis of metabolic disease in the neonate. Developmental Medicine and Child Neurology 1990; 32: 79-83.
37. Chaves-Carballo, E. Detection of inherited neurometabolic disorders. A practical clinical approach. Pediatric Clinics of North America 1992; 39: 801-820.
38. Rosenbloom, L. Chronic central nervous system disease in childhood. In: (Ed D. Hull). Recent Advances in Paediatrics. Edinburgh: Churchill-Livingstone, 1981, pp. 213-236.
39. Wilson, J. Investigation of degenerative disease of the central nervous system. Archives of Disease in Childhood 1972; 47: 163-170.
40. Hoogerbrugge, P.M., Brouwer, O.F., Bordigoni P. et al. Allogenic bone marrow transplantation for lysosomal storage diseases. Lancet 1995; 345: 1398-1402.
41. Krivit, W., Lockman, L.A., Watkins, P.A., Hirsch, J. and Shapiro, E.G. The future for treatment by bone marrow transplantation for adrenoleucodystrophy, metachromatic leucodystrophy, globoid cell leukodystrophy and Hurler syndrome. Journal of Inherited Metabolic Disease 1995; 18: 398-412.
42. Walkley, S.U. and Dobrenis, K. Bone marrow transplantation for lysosomal diseases. Lancet 1995; 345: 1382-1382.
43. Appleton, R.E., Farrell, K., Applegarth, D.A., Dimmick, J.E., Wong, L.T.K. and Davidson, A.G.F. The high incidence of valporate hepatotoxicity in infants may relate to familial metabolic defects. Canadian Journal of Neurological Sciences 1990; 17: 145-148.
44. Lenn, N.J., Ellis, W.G., Washburn, E.R. and Ruebner, B. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate. Epilepsia 1990; 31: 578-583.
45. Bicknese, A.R., May, W., Hickey, W.F. and Dodson, W.E. Early childhood hepato-cerebral degeneration misdiagnosed as valproate hepatotoxicity. Annals of Neurology 1992; 32: 767-775.
46. Kossack, B.D., Schmidt-Sommerfeld, E., Schoeller, D.A., Rinaldo, P., Penn, D. and Tonsgard, J.H. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology 1993; 43: 2362-2368.